Journal
IMMUNITY
Volume 33, Issue 6, Pages 955-966Publisher
CELL PRESS
DOI: 10.1016/j.immuni.2010.11.020
Keywords
-
Categories
Funding
- NRSA [5T32DK007296-30]
- National Heart, Lung, and Blood Institute [2T32HL007317-31]
- Juvenile Diabetes Research Foundation [24-2007-420]
- National Institutes of Health [CA109673]
Ask authors/readers for more resources
Plasmacytoid dendritic cells (pDCs) mediate type 1 interferon (IFN-I) responses to viruses that are recognized through the Toll-like receptor 7 (TLR7) or TLR9 signaling pathway. However, it is unclear how pDCs regulate the antiviral responses via innate and adaptive immune cells. We generated diphtheria toxin receptor transgenic mice to selectively deplete pDCs by administration of diphtheria toxin. pDC-depleted mice were challenged with viruses known to activate pDCs. In murine cytomegalovirus (MCMV) infection, pDC depletion reduced early IFN-I production and augmented viral burden facilitating the expansion of natural killer (NK) cells expressing the MCMV-specific receptor Ly49H. During vesicular stomatitis virus (VSV) infection, pDC depletion enhanced early viral replication and impaired the survival and accumulation of virus-specific cytotoxic T lymphocytes. We conclude that pDCs mediate early antiviral IFN-I responses and influence the accrual of virus-specific NK or CD8(+) T cells in a virus-dependent manner.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available